Drug exceptional access programs (DEAPs) exist across Canada to address gaps in access to pharmaceuticals. These programs circumvent standard procedures, raising epistemic, economic, social and political issues. This commentary provides insights into these issues by revealing the context and procedures on which these programs depend.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964648 | PMC |
http://dx.doi.org/10.1186/s12910-024-01038-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!